First Time Loading...

Xiamen Kingdomway Group Co
SZSE:002626

Watchlist Manager
Xiamen Kingdomway Group Co Logo
Xiamen Kingdomway Group Co
SZSE:002626
Watchlist
Price: 13.95 CNY -0.78% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one Xiamen Kingdomway Group Co stock under the Base Case scenario is 20.48 CNY. Compared to the current market price of 13.95 CNY, Xiamen Kingdomway Group Co is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
20.48 CNY
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
85
vs Industry
41
Median 3Y
4.1
Median 5Y
3.8
Industry
2.3
Forward
2.5
More Details
56.1
P/E
P/E
Price to Earnings
56.1
vs History
19
vs Industry
7
Median 3Y
27.3
Median 5Y
24
Industry
22.2
Forward
20.9
More Details
10.8
P/OCF
P/OCF
Price to OCF
10.8
vs History
80
vs Industry
34
Median 3Y
17.9
Median 5Y
16.2
Industry
16.7
More Details
35.3
P/FCFE
P/FCFE
Price to FCFE
35.3
vs History
39
vs Industry
16
Median 3Y
35
Median 5Y
29.8
Industry
22.6
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
95
vs Industry
36
Median 3Y
3.4
Median 5Y
3.6
Industry
2
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
88
vs Industry
41
Median 3Y
4
Median 5Y
3.9
Industry
2.5
Forward
2.5
More Details
7.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.4
vs History
80
vs Industry
29
Median 3Y
10
Median 5Y
9.6
Industry
5
More Details
44.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
44.5
vs History
19
vs Industry
7
Median 3Y
22.2
Median 5Y
19.9
Industry
13.2
Forward
11.4
More Details
44.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
44.5
vs History
19
vs Industry
9
Median 3Y
22.2
Median 5Y
19.9
Industry
16.5
More Details
10.5
EV/OCF
EV/OCF
Enterprise Value to OCF
10.5
vs History
84
vs Industry
36
Median 3Y
18.5
Median 5Y
16.5
Industry
15.5
More Details
14.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.6
vs History
79
vs Industry
25
Median 3Y
27.4
Median 5Y
23.3
Industry
17.2
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
95
vs Industry
39
Median 3Y
2.7
Median 5Y
2.9
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Xiamen Kingdomway Group Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Xiamen Kingdomway Group Co
SZSE:002626
8.5B CNY 2.8 56.1 44.5 44.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.4
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.5 10

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.